Stories
Sun Pharma Board Approves Plan to Raise Rs 10,000 Crore via NCDs
N
News18•13-10-2026, 14:30
Sun Pharma Board Approves Plan to Raise Rs 10,000 Crore via NCDs
- •Sun Pharmaceutical Industries announced that its board approved raising up to Rs 10,000 crore through non-convertible debentures.
- •The decision involves issuing listed, rated, unsecured, redeemable NCDs on a private placement basis in one or more tranches.
- •Gautam Doshi has resigned as a Non-Executive, Independent Director of the company with immediate effect due to personal reasons.
Key Questions Answered
Sun Pharmaceutical Industries announced that its board of directors approved a proposal to raise funds of up to Rs 10,000 crore through the issuance of non-convertible debentures (NCDs).
The board approved the issuance of listed, rated, unsecured, redeemable NCDs on a private placement basis in one or more tranches and/or series up to an aggregate amount of Rs 10,000 crore.
Gautam Doshi resigned as a Non-Executive, Independent Director with immediate effect, citing personal reasons.
